These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11905629)

  • 1. The dangers of subgroup analysis.
    Stephens R
    Lancet Oncol; 2001 Jan; 2(1):9. PubMed ID: 11905629
    [No Abstract]   [Full Text] [Related]  

  • 2. Should subgroup analysis of randomized clinical trials have a direct impact on clinical practice?
    Bria E; Di Maio M; Cuppone F; Nisticò C; Cognetti F; Giannarelli D
    J Clin Oncol; 2007 Feb; 25(5):605-6; author reply 606-7. PubMed ID: 17290074
    [No Abstract]   [Full Text] [Related]  

  • 3. Interim analysis for randomized clinical trials: simulating the predictive distribution of the log-rank test statistic.
    Chang MN; Shuster JJ
    Biometrics; 1994 Sep; 50(3):827-33. PubMed ID: 7981402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategy for randomised clinical trials in rare cancers.
    Tan SB; Dear KB; Bruzzi P; Machin D
    BMJ; 2003 Jul; 327(7405):47-9. PubMed ID: 12842959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised controlled trials in oncology closed early for benefit: trends in methodology, results, and interpretation.
    Booth CM; Ohorodnyk P; Zhu L; Tu D; Meyer RM
    Eur J Cancer; 2011 Apr; 47(6):854-63. PubMed ID: 21296570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strength of accumulating evidence and data monitoring committee decision making.
    George SL; Freidlin B; Korn EL
    Stat Med; 2004 Sep; 23(17):2659-72. PubMed ID: 15316949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Responsibilities of biostatistics for evaluation of treatment results in tumor therapy].
    Guggenmoos-Holzmann I
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():65-8. PubMed ID: 1983629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical issues in interpreting clinical trials.
    DeMets DL
    J Intern Med; 2004 May; 255(5):529-37. PubMed ID: 15078496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical considerations for the next generation of clinical trials.
    Wu W; Shi Q; Sargent DJ
    Semin Oncol; 2011 Aug; 38(4):598-604. PubMed ID: 21810519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The randomized controlled trial.
    Stel VS; Zoccali C; Dekker FW; Jager KJ
    Nephron Clin Pract; 2009; 113(4):c337-42. PubMed ID: 19752576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Design and conduct of randomized controlled trials (RCTs)].
    Park DH; Baik SK
    Korean J Hepatol; 2006 Sep; 12(3):309-14. PubMed ID: 16998284
    [No Abstract]   [Full Text] [Related]  

  • 12. A guide to sample size and interim analysis in clinical trials.
    Rademaker AW
    Contemp Urol; 1994 Feb; 6(2):43-4. PubMed ID: 10146676
    [No Abstract]   [Full Text] [Related]  

  • 13. Panel discussion 1.
    Dickersin K; Williams G; George S
    Clin Trials; 2012 Dec; 9(6):696-704. PubMed ID: 23250943
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnostics for assumptions in moderate to large simple clinical trials: do they really help?
    Ganju J
    Stat Med; 2006 May; 25(10):1799-800. PubMed ID: 16639774
    [No Abstract]   [Full Text] [Related]  

  • 15. Intention-to-treat or efficacy analysis?
    Horne D
    Br J Gen Pract; 2003 Apr; 53(489):324; author reply 324-5. PubMed ID: 12879836
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomised controlled trials (RCTs)--essentials.
    Chan YH
    Singapore Med J; 2003 Feb; 44(2):60-3. PubMed ID: 14503778
    [No Abstract]   [Full Text] [Related]  

  • 17. A note on non-parametric ANCOVA for covariate adjustment in randomized clinical trials.
    Chen X
    Stat Med; 2005 May; 24(9):1449-52; author reply 1452. PubMed ID: 15812844
    [No Abstract]   [Full Text] [Related]  

  • 18. Separation of health and statistics.
    Church TR
    J Natl Cancer Inst; 2008 Apr; 100(7):452-3. PubMed ID: 18364500
    [No Abstract]   [Full Text] [Related]  

  • 19. Rejoiner to Fox.
    Speca M
    Psychooncology; 1999; 8(3):276. PubMed ID: 10390743
    [No Abstract]   [Full Text] [Related]  

  • 20. Concealed allocation in randomised trials.
    Elkins M
    J Physiother; 2013 Jun; 59(2):134-6. PubMed ID: 23663807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.